- Report
- October 2024
- 193 Pages
From €3122EUR$3,545USD£2,745GBP
€3469EUR$3,939USD£3,050GBP
- Report
- October 2024
- 188 Pages
From €3122EUR$3,545USD£2,745GBP
€3469EUR$3,939USD£3,050GBP
- Report
- October 2024
- 191 Pages
From €3122EUR$3,545USD£2,745GBP
€3469EUR$3,939USD£3,050GBP
- Report
- March 2025
- 146 Pages
Global
From €1982EUR$2,250USD£1,742GBP
- Report
- March 2025
- 99 Pages
Global
From €1982EUR$2,250USD£1,742GBP
- Report
- June 2025
- 151 Pages
Global
From €2312EUR$2,625USD£2,032GBP
€3083EUR$3,500USD£2,710GBP
- Report
- June 2025
- 194 Pages
Global
From €4096EUR$4,650USD£3,600GBP
- Report
- June 2025
- 146 Pages
Global
From €2245EUR$2,549USD£1,974GBP
€2641EUR$2,999USD£2,322GBP
- Report
- September 2025
- 114 Pages
Global
From €4096EUR$4,650USD£3,600GBP
- Report
- July 2025
- 184 Pages
Global
From €4096EUR$4,650USD£3,600GBP
- Report
- July 2025
- 134 Pages
Global
From €4096EUR$4,650USD£3,600GBP
- Report
- July 2025
- 155 Pages
Global
From €4096EUR$4,650USD£3,600GBP
- Report
- July 2025
- 186 Pages
Global
From €4096EUR$4,650USD£3,600GBP
- Report
- June 2025
- 65 Pages
Global
From €2598EUR$2,950USD£2,284GBP
- Report
- May 2025
- 175 Pages
Global
From €4096EUR$4,650USD£3,600GBP
- Report
- May 2025
- 188 Pages
Global
From €4096EUR$4,650USD£3,600GBP
- Report
- April 2025
- 164 Pages
Global
From €4096EUR$4,650USD£3,600GBP
- Report
- December 2024
- 125 Pages
Global
From €4096EUR$4,650USD£3,600GBP
- Report
- October 2024
- 197 Pages
From €3122EUR$3,545USD£2,745GBP
€3469EUR$3,939USD£3,050GBP
- Report
- October 2025
- 150 Pages
Global
From €5240EUR$5,950USD£4,606GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more